New algorithms for treating homozygous familial hypercholesterolemia

We reviewed current and future therapeutic options for patients with homozygous familial hypercholesterolemia (HoFH) and place this evidence in context of an adaptable treatment algorithm. RECENT FINDINGS: Lowering LDL-C levels to normal in patients with HoFH is challenging, but a combination of mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tromp, Tycho R., Cuchel, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
THERAPY AND CLINICAL TRIALS: Edited by Erik S.G. Stroes and Gerald F. Watts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640271/
https://www.ncbi.nlm.nih.gov/pubmed/36206078
http://dx.doi.org/10.1097/MOL.0000000000000853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640271/
https://www.ncbi.nlm.nih.gov/pubmed/36206078
http://dx.doi.org/10.1097/MOL.0000000000000853

Ejemplares similares